AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
As the cost of medication soars, patients are turning to online coupons and financial assistance programs.
In 2021, Humira, the blockbuster biologic that has for years been the highest grossing drug in the world, accomplished something that no drug had previously achieved when its global revenues topped $20 billion.
U.S. drugmaker Merck & Co (MRK.N) hopes to patent a new formulation of its $20 billion cancer immunotherapy Keytruda that can be injected under the skin, allowing it to protect its best-selling drug from competition expected as soon as 2028.
More than 1.3 million American adults with diabetes skipped doses, delayed buying or otherwise rationed doses of insulin due to escalating cost of the life-saving medication, a new study found.
For decades Americans have spent more on prescription drugs than people in other countries. The Biden Administration has been involved in ongoing efforts to stem this trend, making prescription drugs more affordable to both improve public health and provide economic relief to Americans.
A bipartisan group of six U.S. senators said in a letter Wednesday that the U.S. Patent and Trademark Office should take measures to combat "patent thickets" that pharmaceutical companies allegedly use to stifle competition and inflate drug prices.
The Federal Trade Commission announced today that it will launch an inquiry into the prescription drug middleman industry, requiring the six largest pharmacy benefit managers to provide information and records regarding their business practices.
While momentum to enact the Build Back Better Act (BBBA) has stalled in Congress, public support for legislation to lower prescription drug costs is likely to persist, particularly in light of concerns about rising prices due to inflation.
Imagine facing a life-threatening diagnosis only to be told by your insurance company that you can’t get the medicine you need when you need it.